Letters |

The Changing Treatment Paradigm for Acute Otitis Media—Reply

Michael E. K. Moffatt, MD, FRCPC; Anita L. Kozyrskyi, BScPhm, MSc; Terry P. Klassen, MD, MSc; Daniel S. Sitar, BScPhm, PhD
JAMA. 1998;280(22):1903-1904. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-22-jac80017.
Text Size: A A A
Published online


In Reply.—We agree with Dr Cantekin's call for a large, multicenter, randomized controlled trial to address the question of whether any antibiotic is indicated for treatment of children with AOM. If the primary outcome of treatment is the status of the eardrum and hearing, the evidence currently available makes it predictable that a randomized controlled trial comparing antibiotic with placebo will show similar results for each group, at least at 3 months and probably at 1 month. However, we do not believe that the evidence is sufficient to advocate that physicians in the United States "cease prescribing antibiotics for AOM." The meta-analysis by Del Mar et al1 was well done, but it was not completely negative. There was less pain at 2 to 7 days in patients treated with antibiotics, not an inconsequential issue for children and parents. We do not have studies that look at the safety and efficacy of other methods of pain control in children with AOM. To ascertain whether children who do not receive antibiotics initially are at increased risk of rare complications, such as mastoiditis or meningitis, may not be discernible in a randomized controlled trial because the sample size would need to be quite large. Surveillance with use of databases in jurisdictions in which a lower rate of antibiotic usage is documented would be important to ensure that this is a safe approach. In the Netherlands, where antibiotics are prescribed for 30% of AOM cases, no increase in such complications has been documented.2


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.